Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Intensive Care 11 , 123 (2021)
They cannot be
It acts from a lack of equilibrium between two neurotransmitters in the basal ganglia: dopamine (inhibitory) and acetylcholine (excitatory)
J Internal Med
A: Typically one capsule per day or as directed by a healthcare professional
US$ 25.81
US$ 26.79
US$ 26.22
US$ 22.36
US$ 25.12
US$ 22.35
